Prana Biotechnology Limited (ADR) (NASDAQ:PRAN)

50daymovingshort (36.67) Submitted: 4/10/2013 5:11:45 AM : Start Price: $2.26 PRAN Score: +0.42

This pick was made because its below the 50day moving average as of April 10th.
The whole list I perused through below 50dmva for 4/10/13 were;
AMZN,SIRI,PRAN,PCYC,CNQR,PCLN,CRM,LULU,CVLT,NFLX,ULTI,CTXS

These tickers were picked from my tracking universe of the following tickers:
CCI,AMZN,SIRI,LMT,PNRA,SBAC,RPRX,PRAN,MDVN,VZ,ALXN,PCYC,CNQR,INFI,VRTX,PCLN,CRM,LULU,CVLT,NFLX,OPEN,GMCR,N,CAR,REGN,T,SBUX,MO,ULTI,MAR,EQIX,CTXS,CLH,BLL

This was supposed to be a simple tracking blog post rather than a pitch but as a new player, it takes a couple of days to be approved for blog posting...oh well. Hopefully I remember to look back at these pitches.

usubanas (99.41) Submitted: 4/3/2013 10:13:05 AM : Start Price: $1.62 PRAN Score: +20.68

Company updates on 4/3/13:

Alzheimer's Ph2 trial will be completed in December 2013
Huntington's Ph2 Results anticipated October 2013

Long shot, but with a 65M market cap if any of those work it's easily a 10-bagger.

TMFBlacknGold (99.38) Submitted: 11/5/2012 10:33:06 AM : Start Price: $2.70 PRAN Score: +29.36

This company has only $5.62 million in shareholders' equity. Certainly not surprising for a speculative biopharma company, but should be an easy red-thumb after the recent run-up.

zzlangerhans (99.75) Submitted: 9/20/2012 7:57:24 AM : Start Price: $2.09 PRAN Score: -0.88

With stocks like Prana, CAPS offers you a game of whack-a-mole. Because of silly eligibility parameters, the stock is unratable most of the time but makes brief appearances in the ratable zone. When the share price moves out of its appropriate range, you just have to check the stock every day and WHACK it as soon as you can.

That's exactly what I did with Prana yesterday around mid-day. The only problem was that I didn't have any fresh material to write about, having harangued this horrible company with minimal long-term prospects so many times in the past.

Prana solved that problem for me about five minutes after I entered my underperform. They issued a press release to highlight positive remarks from a sell-side analyst at MLV & Co, an obscure brokerage shilling for clients, and the stock immediately gapped up 15%.

Can you imagine a real company like Gilead coming out with a press release to announce that an analyst had upped their price target on the stock, or thought their latest pipeline candidate was really groovy? The street would fall over laughing. But with a low float, poorly-tracked stock like Prana whose shareholders are mostly gullible retirees with tube socks up to their knees and rusty metal detectors in the closet, this type of machination actually has a short-term effect.

In reality, Prana doesn't have enough cash to complete their phase II trials of PBT2 in Huntington's and Alzheimer's and needs to raise more cash in sneaky ATM financings (that's when you use your shareholder base as an ATM). So periodically we get these price spikes on fluff which die down once the cash is raised. I wonder who will broker the financing - possibly MLV & Co?

phatchips767 (< 20) Submitted: 3/28/2012 8:16:24 PM : Start Price: $1.72 PRAN Score: +19.29

australian pharma. company works with alzheimers cures. mf rated it 5 stars , pe was -12.

sohiab (< 20) Submitted: 2/27/2008 2:41:51 PM : Start Price: $4.56 PRAN Score: -73.71

Leading edge company doing amazing things in research.